INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

74,396 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
6
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Option exercise
M—
125.0K sh
Sep 13, 2026Sep 15, 2026
Page 433 of 1860
← PrevNext →
traded Sep 13, 2026
+2d
SEC Form 4

Evidence

5
BB
Ball BryanSee remarks
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
91.6K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

5
HJ
Hanson JohnChief of Staff
OKLOOklo Inc.
Option exercise
M—
961 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

5
MN
Mesa NildaDirector
UTHRUNITED THERAPEUTICS Corp
Option exercise
M$14K
130 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

5
CE
Cooper Jeffrey ElliottChief Financial Officer
GWREGuidewire Software, Inc.
Option exercise
M—
37.8K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

5
RA
Renner AlexandraChief Product Officer
OKLOOklo Inc.
Option exercise
M—
1,202 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

5
RA
Renner AlexandraChief Product Officer
OKLOOklo Inc.
Option exercise
M—
1,202 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

5
MN
Mesa NildaDirector
UTHRUNITED THERAPEUTICS Corp
Option exercise
M—
130 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

5
HJ
Hanson JohnChief of Staff
OKLOOklo Inc.
Option exercise
M—
961 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

5
MP
Mullen John PPresident
GWREGuidewire Software, Inc.
Option exercise
M—
75.2K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

5
BB
Ball BryanSee remarks
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
91.6K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

5
NV
Narayanadas VivekGeneral Counsel & Secretary
OKLOOklo Inc.
Option exercise
M—
210 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$27K
13.8K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

5
NV
Narayanadas VivekGeneral Counsel & Secretary
OKLOOklo Inc.
Option exercise
M—
210 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

4
PL
Phillips Ronald LEVP and CHRO
SYYSYSCO CORP
Open-market sale · 10b5-1 plan
SELL$80K
960 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

3
AM
Abernethy MattChief Financial Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award · 10b5-1 plan
A—
5,020 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

3
BW
Boyer David W.Chief Corp. Affairs Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award · 10b5-1 plan
A—
3,587 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

3
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M$24K
18.0K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

2
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Option exercise
M—
123.1K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

2
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
194.0K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

2
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M$122K
15.0K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

2
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M$630K
50.0K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

2
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Gift · 10b5-1 plan
G—
8,800 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

2
DS
Dotan SaarEVP Countries & BD
ZIMZIM Integrated Shipping Services Ltd.
Option exercise
M—
22.4K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

2
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
194.0K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

2
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Tax withholding · 10b5-1 plan
F$482K
31.5K sh
Sep 12, 2026Sep 15, 2026
traded Sep 12, 2026
+3dSEC Form 4

Evidence

1
MR
Moll Laurent RChief Operating Officer
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$190K
9,119 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

0
PL
Phillips Ronald LEVP and CHRO
SYYSYSCO CORP
Option exercise · 10b5-1 plan
M$67K
960 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

0
PL
Phillips Ronald LEVP and CHRO
SYYSYSCO CORP
Open-market sale · 10b5-1 plan
SELL$4,806
57 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

0
PL
Phillips Ronald LEVP and CHRO
SYYSYSCO CORP
Tax withholding · 10b5-1 plan
F$12K
149 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

0
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M—
18.0K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

0
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M—
13.5K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

0
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
150.0K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

0
WT
Weingarten TomerDirector, President, CEO
SSentinelOne, Inc.
Derivative conversion · 10b5-1 plan
C—
57.9K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

0
WT
Weingarten TomerDirector, President, CEO
SSentinelOne, Inc.
Derivative conversion · 10b5-1 plan
C—
57.9K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

0
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M$110K
13.5K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

0
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M—
15.0K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

0
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
150.0K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

0
MR
Moll Laurent RChief Operating Officer
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$2,175
100 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

0
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M—
31.0K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence